Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marie Mannino
Institution:
Bristol-Myers Squibb (United States)
Observed institutions:
F. Hoffmann-La Roche AG,
Bristol-Myers Squibb (United States),
Queens Hospital Center
OpenAlex ID:
A5111884199
Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
2017
·
Stephane Nave
, Rachelle S. Doody
, et al.
·
Journal of Alzheimer s Disease
·
52
PDF
Clinical trial considerations on male contraception and collection of pregnancy information from female partners
2012
·
Maria Longauer Banholzer
, Heinrich Buergin
, et al.
·
Journal of Translational Medicine
·
14
PDF
A randomized, double‐blind, placebo‐controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease
2024
·
Darren Bentley
, Marie Mannino
, et al.
·
Clinical and Translational Science
·
6
PDF
Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update
2016
·
Maria Longauer Banholzer
, Christoph Wandel
, et al.
·
Clinical and Translational Medicine
·
4
PDF
Impotence in scleroderma
1988
·
Marie Mannino
, Catherine Marino
·
Arthritis & Rheumatism
·
2
Erratum to: Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update
2016
·
Maria Longauer Banholzer
, Christoph Wandel
, et al.
·
Clinical and Translational Medicine
PDF
Clinical trial considerations on male contraception and collection of pregnancy information from female partners
2012
·
Maria Longauer-Banholzer
, Heinrich Buergin
, et al.
·
Reproductive Toxicology
Show more works
View as search
Works count:
8
Citation count:
78
H-index:
4
I10-index:
2
Year
Topic
Type